Mike Kelly bought Colgate-Palmolive Company (NYSE: CL)
Mike Kelly (R-PA), a U.S. Representative, has disclosed 1 trade in Colgate-Palmolive Company (CL) since 2016, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Mike Kelly bought $1,001 - $15,000 of Colgate-Palmolive Company (NYSE: CL) on September 12, 2016. Since that trade, CL is up +61.73% against the S&P 500 up +294.83%, an outperformance of -233.10%.
Data updated
Mike Kelly's CL trades vs the price
CL is up +61.73% since Mike Kelly bought on September 12, 2016, versus +294.83% for the S&P 500.
Performance since this trade
All Mike Kelly CL trades
Mike Kelly & CL trading FAQ
Is it legal for Mike Kelly to trade Colgate-Palmolive Company (CL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Colgate-Palmolive Company (CL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mike Kelly buy CL?
Mike Kelly disclosed a purchase of $1,001 - $15,000 of Colgate-Palmolive Company (CL) on September 12, 2016, according to public STOCK Act filings.
How has CL performed since Mike Kelly's trade?
Since Mike Kelly bought CL on September 12, 2016, the stock is up +61.73%, versus +294.83% for the S&P 500 over the same period, an outperformance of -233.10%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CL trades?
Quantellect tracks every disclosed congressional trade in Colgate-Palmolive Company (CL) on the Colgate-Palmolive Company congressional trading page, which aggregates filings across all members of Congress.
Mike Kelly's CL tradesAll congressional filings for Colgate-Palmolive CompanyMike Kelly's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.